arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

MEDIFAST INC

MED
$12.61 ▲ +0.50 (+4.13%) at close
Consumer Staples ·Miscellaneous Food Preparations & Kindred Products ·USMiscellaneous Food Preparations & Kindred Products
18 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
27
Health
Poor
Bearish
auto_awesome

Analytical Summary

MEDIFAST INC faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $138.5M
Dividend Yield
Revenue Growth -36.0%
Op. Margin -3.7%
ROIC -23.7%
FCF / Share $0.11
Trailing P/E
Price / Book 0.7x
FCF Yield 0.9%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$385.79M
↓ -36.0%
Net Income Profit after all expenses
$-18.67M
↓ -993.0%
Operating Margin Operating profit as % of sales
-3.7%
↓ -871.2% 21th
FCF / Share Free cash flow per share
$0.11
↓ -92.7%
Long-Term Debt Long-term obligations
$0.00
↓ -100.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
23
Returns
35
Cash Quality
20

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters